Literature DB >> 18382998

First-trimester ADAM12s as early markers of trisomy 21: a promise still unfulfilled?

Kevin Spencer1, Nicholas J Cowans, Niels Uldbjerg, Niels Tørring.   

Abstract

BACKGROUND: Here we study the levels of ADAM12s prior to and after 10 weeks of gestation to establish further the effectiveness or otherwise of ADAM12s as an early screening marker.
MATERIALS AND METHODS: Samples collected as part of routine first-trimester screening were retrieved from storage at - 80 degrees C. In total, 55 samples from pregnancies with trisomy 21 were identified, 31 collected between the 6th and 9th weeks of gestation and 24 collected after the 10th week. A series of 567 gestational age-matched samples collected during the same period formed the control group.
RESULTS: The median, multiples of the median (MoM) ADAM12s, at a median gestation of 10.0 weeks was 0.66, which was significantly lower than in the controls (p = < 0.001) when compared by Mann-Whitney test. The median MoM in those cases (n = 31) collected prior to 10 weeks was 0.618 MoM at a median gestation of 9.1 weeks. In those collected prior to 9 weeks (n = 14) the median was 0.596 at a median gestation of 8.6 weeks.
CONCLUSIONS: The data from this study does not support data from a previous study showing ultra-low levels of ADAM12s in pregnancies affected by trisomy 21 prior to 10 weeks of gestation. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18382998     DOI: 10.1002/pd.1978

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  5 in total

1.  A disintegrin and metalloprotease protein-12 as a novel marker for the diagnosis of ectopic pregnancy.

Authors:  Mary E Rausch; Lynn Beer; Mary D Sammel; Peter Takacs; Karine Chung; Alka Shaunik; David Speicher; Kurt T Barnhart
Journal:  Fertil Steril       Date:  2011-02-01       Impact factor: 7.329

Review 2.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

3.  First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker.

Authors:  Niels Tørring; Susan Ball; Dave Wright; Gaïané Sarkissian; Marie Guitton; Bruno Darbouret
Journal:  Reprod Biol Endocrinol       Date:  2010-10-29       Impact factor: 5.211

4.  Discovery of novel serum biomarkers for prenatal Down syndrome screening by integrative data mining.

Authors:  Jeroen L A Pennings; Maria P H Koster; Wendy Rodenburg; Peter C J I Schielen; Annemieke de Vries
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

5.  Maternal serum disintegrin and metalloprotease protein-12 in early pregnancy as a potential marker of adverse pregnancy outcomes.

Authors:  Jiexia Yang; Jing Wu; Fangfang Guo; Dongmei Wang; Keyi Chen; Jie Li; Li Du; Aihua Yin
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.